Curative becomes a unicorn with $150 million Series B for its zero-cost health plan
The Austin health insurer reached a $1.275 billion valuation on a round led by the Upside Vision Fund as it plans a national expansion.
AUSTIN — Curative, the Austin health insurer that markets a plan with no copays, deductibles or coinsurance for members who complete an annual preventive visit, has raised more than $150 million in Series B funding at a $1.275 billion valuation, crossing into unicorn territory.
The December round was led by TED chairman Chris Anderson's Upside Vision Fund, with Justin Mateen's JAM Fund investing $47.5 million. Galaxy Digital's Mike Novogratz, Stanley Druckenmiller's Duquesne Family Office and DCVC also participated.
Curative says it now serves more than 1,200 employer clients and over 165,000 members and has reached profitability less than three years after launch. The company plans to use the capital to expand nationally, starting with the Mid-Atlantic, beyond its current footprint in Texas, Florida and Georgia.
Why it matters
Health insurance is a brutally capital-intensive, regulation-heavy business that few startups survive. Curative reaching profitability and unicorn status while pursuing a no-out-of-pocket-cost design is a notable counterexample, and it keeps a fast-growing insurer headquartered in Austin as it pushes into new states.
Whether the zero-cost model holds up as Curative scales into more expensive, higher-utilization markets will be the key question for its national ambitions.
Reported by Next in Austin. Based on reporting from BusinessWire.
Covers who's raising, who's hiring, and who's next in Austin.
More from Funding
All Funding →